ARTICLE | Company News
Global Health Ventures, Pacific Therapeutics deal
June 28, 2010 7:00 AM UTC
The companies signed a binding letter of intent giving Global Health exclusive rights to co-develop Pacific's PTL-202 for pulmonary indications and commercialize the compound in North America. PTL-20...